Latest Breaking News On - Red cell therapeutics - Page 1 : comparemela.com

Rubius Therapeutics (RUBY) Announces Process to Explore Strategic Alternatives, Names New President and CEO

Rubius Therapeutics (RUBY) Announces Process to Explore Strategic Alternatives, Names New President and CEO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Dannielle appelhansPabloj cagnoniMaiken keson brookesPepe carmonaExchange commissionRubius therapeutics incWall streetRed cell therapeuticsRed cell therapeutic

Rubius stock slumps 26% as tumor trials of RTX-240, RTX-224 axed, cuts 75% workforce

Rubius Therapeutics (RUBY) said it was discontinuing ongoing trials of RTX-240 and RTX-224 for advanced solid tumors and was reducing its workforce by 75%. Rubius is restructuring.

Rhode islandUnited statesPablo cagnoniKlaus vedfeltRed cell therapeuticsRubius president

Rubius Therapeutics Announces Strategic Update

Rubius Therapeutics Announces Strategic Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Rhode islandUnited statesUnited kingdomPabloj cagnoniContactlori murrayRubius therapeutics incExchange commissionCorporate affairsBoston globeCash runway extendedOngoing phaseAdvanced solidWebcast scheduled todayRed cell therapeuticsRubius therapeuticsRed cell

Rubius Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

Rubius Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomRhode islandUnited statesSan franciscoMarissa hanifyLori murrayPabloj cagnoniSusanne schaffertRubius therapeutics incExchange commissionCorporate communicationsBoston globeCorporate affairsPreclinical data presentedMeeting demonstrating preventionStringent preclinical

Rubius Therapeutics : Appoints Susanne Schaffert, Ph D , to its Board of Directors - Form 8-K

Rubius Therapeutics Appoints Susanne Schaffert, Ph.D., to its Board of Directors CAMBRIDGE, Mass., July 14, 2022 - Rubius Therapeutics, Inc. , a clinical-stage. | July 14, 2022

Rhode islandUnited statesUnited kingdomLori murrayPabloj cagnoniSusanne schaffertAnne prenerGlobal novartis oncology leadership teamExchange commissionRubius therapeutics incUniversity of erlangen germanyBoston globeCorporate affairsRubius therapeutics appoints susanne schaffertRed cell therapeuticsNovarti oncology business